AVXL Anavex Life Sciences Corp.
$2.62▼ -1.50%
Healthcare
Other
After hours
$2.62▲ +0.00%
Sep 11, 7:30 PM ET
Volume 624.3K
Avg Volume (10D) 615.4K
Key Metrics & Fundamentals
Market Cap
$242.87M
P/E Ratio
–
Div Yield
–%
52W Range
2.26 - 10.38
% vs 50 MA
-8.73%
% vs 200 MA
-24.64%
RSI-14
38.0
MACD Histogram
-0.0700
Beta (1Y vs SPY)
1.70
Free Cash Flow
-$9.10M
Gross Rev
$0
Gross Profit
$0
EBITDA
$6.79M
COGS
–
Operating Exp
-$6.77M
Operating Income
$6.77M
EBIT
$6.77M
Pretax Income
$7.82M
Net Income
$7.82M
EPS (Diluted)
0.08
Price & Volume History
Loading chart…
Recent News
PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign
GlobeNewswire · Sep 10, 2026 6:45 PM
PVG Asset Management Issues Important Information About Anavex Life Sciences (AVXL)
GlobeNewswire · Sep 9, 2026 1:53 PM
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET
GlobeNewswire · Sep 8, 2026 12:00 PM
PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company
GlobeNewswire · Sep 3, 2026 9:46 PM
Anavex Life Sciences Regains Nasdaq Compliance After Filing Quarterly Reports
MT Newswires · Sep 2, 2026 9:37 PM
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement
GlobeNewswire · Sep 2, 2026 8:00 PM
PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting
GlobeNewswire · Sep 1, 2026 9:35 PM
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires · Aug 25, 2026 7:57 PM
Anavex Life Sciences Shares Rise After Q3 Swings to Profit
MT Newswires · Aug 25, 2026 6:52 PM
Anavex Life Sciences Advances Alzheimer’s Phase 3 Planning as Cash Runway Extends Into Fiscal 2028
InvestorsHub · Aug 25, 2026 2:46 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AVXL's money flow as a full page
Social Sentiment
Avg +0.60 · 16 posts
DDNewsTrade$AVXL - Alzheimer’s Drug Shows LONG TERM BENEFITS. New data just released.
r/wallstreetbets · Jul 31, 2025
The post highlights long-term benefits and a ‘moon’ thesis, indicating strong bullish sentiment.
very_positive
+1.00
DDPriceTargetBullish Tetrad
r/wallstreetbets · Jul 25, 2025
The post expresses strong bullish sentiment towards AVXL with ‘significant upside potentials’ and encourages further research.
very_positive
+0.80
DDNewsDiscussionTrade$AVXL - Up $80k on a stock that might fix your grandpa
r/wallstreetbets · Jul 3, 2025
The post describes a significant profit gain and discusses institutional buying, indicating strong bullish sentiment.
very_positive
+1.00
TradeDiscussionDiversified biotech short portfolio - completely tweaked on naked short calls (-20 500$)
r/wallstreetbets · Apr 30, 2025
The author describes AVXL as a 'con-artist' with no profitable product pipeline and expresses concern about its potential for a rapid increase in value.
very_negative
-0.80
NewsDDAVXL releases additional positive data for Alzheimer’s
r/wallstreetbets · Apr 6, 2025
The post highlights positive data and a significant market capitalization opportunity, expressing strong bullish sentiment.
very_positive
+1.00
Page 1 of 4 (16 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.